Year: 2024
Type: article
Abstract: Autoimmunity transpires when the immune system erroneously targets healthy cells, leading to a range of autoimmune disorders. Although medications are available to alleviate symptoms and decelerate disease progression, a definitive cure for autoimmunity continues to be unattainable. Research in immunology and medical science is perpetually advancing, with novel potential findings arising. A viable strategy for tackling autoimmunity involves employing medicines that target the fundamental mechanisms responsible for immune system dysfunction. Certain drugs may regulate certain immune responses or obstruct inflammatory pathways associated with autoimmune illnesses. Moreover, gene-editing technologies such as CRISPR-Cas9 present possible avenues for altering genes associated with autoimmunity and maybe “disabling” the autoimmune response entirely. Despite existing hurdles, including the assurance of therapeutic efficacy and safety, these novel techniques have the potential to transform the management of autoimmunity in the future.
Source: Science Insights
DOI: 10.15354/si.24.pe183
Author: Eugene Gibson
Institution: University of Nevada, Reno
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4405902792